Omnicell Inc logo

OMCL - Omnicell Inc Share Price

$63.09 6.2  11.0%

Last Trade - 8:05pm

Sector
Healthcare
Size
Mid Cap
Market Cap £1.94bn
Enterprise Value £1.88bn
Revenue £720.2m
Position in Universe 1399th / 6323
Bullish
Bearish
Unlock OMCL Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

OMCL Revenue Unlock OMCL Revenue

Net Income

OMCL Net Income Unlock OMCL Revenue

Normalised EPS

OMCL Normalised EPS Unlock OMCL Revenue

PE Ratio Range

OMCL PE Ratio Range Unlock OMCL Revenue

Dividend Yield Range

OMCL Dividend Yield Range Unlock OMCL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
OMCL EPS Forecasts Unlock OMCL Revenue
Profile Summary

Omnicell, Inc. provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is engaged in the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems and related software. The Medication Adherence segment includes the development, manufacturing and selling of consumable medication blister cards, packaging equipment, medication synchronization platform, and ancillary products and services. Its products are used to manage medication administration outside of the hospital setting and include medication adherence products sold under the brand name MTS, Surgichem, SureMed and the Omnicell brand.

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated April 14, 2000
Public Since August 8, 2001
No. of Shareholders: 83
No. of Employees: 2,700
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Global Select Market
Shares in Issue 42,465,814
Free Float (0.0%)
Eligible for
ISAs
SIPPs
OMCL Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for OMCL
Upcoming Events for OMCL
Thursday 23rd April, 2020 Estimate
Q1 2020 Omnicell Inc Earnings Release
Wednesday 13th May, 2020 Estimate
Omnicell Inc Annual Shareholders Meeting
Thursday 23rd July, 2020 Estimate
Q2 2020 Omnicell Inc Earnings Release
Similar to OMCL
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.